Skip to main content
Fig. 2 | BMC Gastroenterology

Fig. 2

From: Efficacy and safety of the combination of camrelizumab and apatinib in the treatment of liver cancer: a systematic review and single-arm meta-analysis

Fig. 2

A Forest plot delineating ORR of camrelizumab in combination with apatinib for liver cancer treatment; B Sensitivity analysis on ORR of camrelizumab in combination with apatinib for liver cancer treatment; C Forest plot of subgroup analysis on ORR of camrelizumab in combination with apatinib as first-line or second-line therapy for liver cancer

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us